Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -29.87M | -33.84M | -26.10M | -26.64M | -29.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 1.125M | 1.135M | 1.181M | 1.264M | 1.307M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 1.718M | 1.351M | 1.353M | 1.466M | 2.241M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 2.843M | 2.486M | 2.534M | 2.73M | 3.548M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | -2.058M | 7.30M | 1.015M | -1.585M | 3.483M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | 2.081M | 1.568M | 2.336M | 1.804M | 1.058M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | -27.00M | -22.49M | -20.22M | -23.69M | -21.54M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.234M | -0.206M | -0.076M | 2.165M | -0.464M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -129.34M | 18.24M | 30.82M | 24.34M | -4.854M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -129.58M | 18.03M | 30.74M | 26.50M | -5.318M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -0.353M | -0.345M | -0.329M | -2.631M | -0.284M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | -0.233M | 160.59M | 0.001M | 0.028M | 0.052M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | -0.136M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Net Cash from Financing Activities | -0.722M | 160.25M | -0.328M | -2.603M | -0.232M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -157.30M | 155.79M | 10.19M | 0.21M | -27.09M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 186.31M | 47.21M | 186.31M | 30.52M | 20.33M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 29.01M | 186.31M | 30.52M | 20.33M | 20.12M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
